MX369671B - Formulaciones con oxidacion reducida. - Google Patents
Formulaciones con oxidacion reducida.Info
- Publication number
- MX369671B MX369671B MX2015011432A MX2015011432A MX369671B MX 369671 B MX369671 B MX 369671B MX 2015011432 A MX2015011432 A MX 2015011432A MX 2015011432 A MX2015011432 A MX 2015011432A MX 369671 B MX369671 B MX 369671B
- Authority
- MX
- Mexico
- Prior art keywords
- formulations
- protein
- methods
- oxidation
- reduced oxidation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Organic Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Lubricants (AREA)
Abstract
La presente invención se refiere a formulaciones que comprenden una proteína en combinación con un compuesto que impide la oxidación de la proteína. La invención también proporciona métodos para elaborar estas formulaciones y métodos para usar estas formulaciones. La invención proporciona además métodos para examinar compuestos para impedir la oxidación de una proteína en una composición de proteína y métodos para prevenir la oxidación de una proteína en una formulación.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361780845P | 2013-03-13 | 2013-03-13 | |
US201361909813P | 2013-11-27 | 2013-11-27 | |
PCT/US2014/026841 WO2014160495A1 (en) | 2013-03-13 | 2014-03-13 | Formulations with reduced oxidation |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015011432A MX2015011432A (es) | 2016-04-27 |
MX369671B true MX369671B (es) | 2019-11-15 |
Family
ID=51625442
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015011432A MX369671B (es) | 2013-03-13 | 2014-03-13 | Formulaciones con oxidacion reducida. |
MX2019013560A MX2019013560A (es) | 2013-03-13 | 2015-09-02 | Formulaciones con oxidacion reducida. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019013560A MX2019013560A (es) | 2013-03-13 | 2015-09-02 | Formulaciones con oxidacion reducida. |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP2968466B1 (es) |
JP (3) | JP6389236B2 (es) |
KR (1) | KR102237885B1 (es) |
CN (2) | CN110075293A (es) |
AU (3) | AU2014243700B2 (es) |
BR (1) | BR112015022484A2 (es) |
CA (2) | CA2904166C (es) |
DK (1) | DK2968466T3 (es) |
ES (1) | ES2688895T3 (es) |
HK (1) | HK1211219A1 (es) |
HR (1) | HRP20181504T1 (es) |
HU (1) | HUE039948T2 (es) |
IL (2) | IL269947B (es) |
LT (1) | LT2968466T (es) |
MX (2) | MX369671B (es) |
MY (1) | MY174679A (es) |
NZ (1) | NZ711566A (es) |
PL (1) | PL2968466T3 (es) |
PT (1) | PT2968466T (es) |
RS (1) | RS57813B1 (es) |
RU (1) | RU2707092C2 (es) |
SG (2) | SG10201705525VA (es) |
SI (1) | SI2968466T1 (es) |
WO (1) | WO2014160495A1 (es) |
ZA (2) | ZA201506876B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112015022475A8 (pt) * | 2013-03-13 | 2019-11-26 | Genentech Inc | formulação líquida e método para impedir a oxidação de uma proteína em uma formulação de proteína |
US10653779B2 (en) | 2013-03-13 | 2020-05-19 | Genentech, Inc. | Formulations with reduced oxidation |
US20140314778A1 (en) | 2013-03-13 | 2014-10-23 | Genentech, Inc. | Formulations with reduced oxidation |
DK3475303T3 (da) | 2016-06-27 | 2021-05-31 | Morphosys Ag | Anti-cd19-antistofformuleringer |
WO2019073996A1 (ja) * | 2017-10-13 | 2019-04-18 | 株式会社タムラテコ | 有害物処理方法およびオゾン発生装置 |
CA3106537A1 (en) | 2018-08-08 | 2020-02-13 | Genentech, Inc. | Use of tryptophan derivatives and l-methionine for protein formulation |
Family Cites Families (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
EP0435911B1 (en) | 1988-09-23 | 1996-03-13 | Cetus Oncology Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
DE68913658T3 (de) | 1988-11-11 | 2005-07-21 | Stratagene, La Jolla | Klonierung von Immunglobulin Sequenzen aus den variablen Domänen |
FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
DE69029036T2 (de) | 1989-06-29 | 1997-05-22 | Medarex Inc | Bispezifische reagenzien für die aids-therapie |
US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
JP3068180B2 (ja) | 1990-01-12 | 2000-07-24 | アブジェニックス インコーポレイテッド | 異種抗体の生成 |
US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
DK0564531T3 (da) | 1990-12-03 | 1998-09-28 | Genentech Inc | Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber |
US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
JPH06507398A (ja) | 1991-05-14 | 1994-08-25 | リプリジェン コーポレーション | Hiv感染治療のための異種複合抗体 |
GB9114948D0 (en) | 1991-07-11 | 1991-08-28 | Pfizer Ltd | Process for preparing sertraline intermediates |
US7018809B1 (en) | 1991-09-19 | 2006-03-28 | Genentech, Inc. | Expression of functional antibody fragments |
WO1993006213A1 (en) | 1991-09-23 | 1993-04-01 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
US5587458A (en) | 1991-10-07 | 1996-12-24 | Aronex Pharmaceuticals, Inc. | Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof |
WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
US5667988A (en) | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
CA2372813A1 (en) | 1992-02-06 | 1993-08-19 | L.L. Houston | Biosynthetic binding protein for cancer marker |
WO1994004690A1 (en) | 1992-08-17 | 1994-03-03 | Genentech, Inc. | Bispecific immunoadhesins |
DE69329503T2 (de) | 1992-11-13 | 2001-05-03 | Idec Pharma Corp | Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierung-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyt beschränkt ist, für die Behandlung von B-Zell-Lymphoma |
US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
US5869046A (en) | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
DE69637481T2 (de) | 1995-04-27 | 2009-04-09 | Amgen Fremont Inc. | Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8 |
AU2466895A (en) | 1995-04-28 | 1996-11-18 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
EP0921855B1 (en) | 1996-08-30 | 2003-11-19 | Upfront Chromatography A/S | Isolation of immunoglobulins |
KR20080059467A (ko) | 1996-12-03 | 2008-06-27 | 아브게닉스, 인크. | 복수의 vh 및 vk 부위를 함유하는 사람 면역글로불린유전자좌를 갖는 형질전환된 포유류 및 이로부터 생성된항체 |
US20080318254A9 (en) | 1997-03-10 | 2008-12-25 | The Regents Of The University Of California | PSCA antibodies and hybridomas producing them |
US20020173629A1 (en) | 1997-05-05 | 2002-11-21 | Aya Jakobovits | Human monoclonal antibodies to epidermal growth factor receptor |
US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
US6610833B1 (en) | 1997-11-24 | 2003-08-26 | The Institute For Human Genetics And Biochemistry | Monoclonal human natural antibodies |
WO1999029888A1 (en) | 1997-12-05 | 1999-06-17 | The Scripps Research Institute | Humanization of murine antibody |
JP2000247903A (ja) * | 1999-03-01 | 2000-09-12 | Chugai Pharmaceut Co Ltd | 長期安定化製剤 |
DK1167537T3 (da) | 1999-03-30 | 2008-11-10 | Japan Tobacco Inc | Fremgangsmåde til fremstilling af et monoklonalt antistof |
US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
PT1222292E (pt) | 1999-10-04 | 2005-11-30 | Medicago Inc | Metodo para regulacao da transcricao de genes exogenos na presenca de azoto |
US7163671B2 (en) * | 2000-02-29 | 2007-01-16 | Chugai Seiyaku Kabushiki Kaisha | Long-term stabilized formulations |
WO2002022573A2 (en) * | 2000-09-15 | 2002-03-21 | The Scripps Research Institute | Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
US6933123B2 (en) * | 2001-04-05 | 2005-08-23 | Yao Xiong Hu | Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers |
CA2447114A1 (en) | 2001-05-16 | 2002-11-21 | Abgenix, Inc. | Human antipneumococcal antibodies from non-human animals |
ATE531390T1 (de) | 2001-08-23 | 2011-11-15 | Genmab As | Interleukin-15-(il-15-)spezifische menschliche antikörper |
EP1428537B1 (en) * | 2001-08-29 | 2008-11-19 | Chugai Seiyaku Kabushiki Kaisha | Stabilized preparations containing antibody |
US20040116350A1 (en) * | 2001-09-17 | 2004-06-17 | Paul Wentworth Jr | Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
EP1590434A4 (en) | 2003-01-17 | 2006-11-29 | Univ New York State Res Found | ASSOCIATED ANTIGEN, ANTIBODIES, AND DIAGNOSIS AND TREATMENT METHODS WITH CONCENTRATED CANNULA CANCER |
US20060104968A1 (en) | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
US7871607B2 (en) | 2003-03-05 | 2011-01-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
JP4999158B2 (ja) | 2003-05-21 | 2012-08-15 | メダレツクス・インコーポレーテツド | 炭疽菌(bachillusanthracis)の感染防御抗原に対するヒトモノクローナル抗体 |
MXPA06006868A (es) * | 2003-12-18 | 2007-03-21 | Scripps Research Inst | Incorporacion selectiva de 5-hiroxitriptofano en proteinas de celulas de mamiferos. |
EP1986674A4 (en) * | 2006-02-13 | 2009-11-11 | Nektar Therapeutics | PROTEIN OR PEPTIDE COMPOSITIONS PROTEIN CONTAINING METHIONINE AND METHOD FOR MANUFACTURING AND USING SAME |
CN101616685B (zh) * | 2006-03-06 | 2013-07-24 | 阿穆尼克斯运营公司 | 非结构化重组聚合物和其应用 |
JP2007319124A (ja) * | 2006-06-02 | 2007-12-13 | Nippon Tablet Kk | 健康食品 |
CA2675638C (en) * | 2007-01-16 | 2015-11-24 | Ipintl, Llc | Composition comprising serotonin for treating metabolic syndrome |
ES2628407T3 (es) * | 2008-04-01 | 2017-08-02 | Antipodean Pharmaceuticals, Inc. | Composiciones y procedimientos para el cuidado de la piel |
JP2012500263A (ja) * | 2008-08-21 | 2012-01-05 | アルヴィン ファーマシューティカルズ インコーポレーティッド | タンパク質の経口投与のための製剤 |
MX2011002372A (es) * | 2008-09-10 | 2011-04-04 | Genentech Inc | Composiciones y metodos para la prevencion de la degradacion oxidativa de proteinas. |
EP2331090B1 (en) * | 2008-09-19 | 2018-01-03 | Pfizer Inc. | Stable liquid antibody formulation |
SG186783A1 (en) * | 2010-06-24 | 2013-02-28 | Genentech Inc | Compositions and methods containing alkylgycosides for stabilizing protein- containing formulations |
RU2447448C1 (ru) * | 2010-08-30 | 2012-04-10 | Государственное образовательное учреждение высшего профессионального образования "Оренбургский государственный университет" | Способ стабилизации антител в водных растворах |
EP2717698A4 (en) * | 2011-06-09 | 2015-01-07 | Requis Pharmaceuticals Inc | ANTIHISTAMINES COMBINED WITH FOOD SUPPLEMENTS TO IMPROVE HEALTH |
JP2014522827A (ja) * | 2011-06-28 | 2014-09-08 | ロイコケア・アクチェンゲゼルシャフト | (ポリ)ペプチドのアンフォールディングを防止し、および/または(ポリ)ペプチドの(リ)フォールディングを誘導するための方法 |
-
2014
- 2014-03-13 JP JP2016502262A patent/JP6389236B2/ja active Active
- 2014-03-13 CA CA2904166A patent/CA2904166C/en active Active
- 2014-03-13 SG SG10201705525VA patent/SG10201705525VA/en unknown
- 2014-03-13 MX MX2015011432A patent/MX369671B/es active IP Right Grant
- 2014-03-13 BR BR112015022484A patent/BR112015022484A2/pt not_active Application Discontinuation
- 2014-03-13 CA CA3113172A patent/CA3113172A1/en not_active Abandoned
- 2014-03-13 RU RU2015143548A patent/RU2707092C2/ru active
- 2014-03-13 SI SI201430883T patent/SI2968466T1/sl unknown
- 2014-03-13 IL IL269947A patent/IL269947B/en unknown
- 2014-03-13 CN CN201811652794.4A patent/CN110075293A/zh active Pending
- 2014-03-13 SG SG11201507043SA patent/SG11201507043SA/en unknown
- 2014-03-13 CN CN201480006214.8A patent/CN104968362B/zh active Active
- 2014-03-13 RS RS20181107A patent/RS57813B1/sr unknown
- 2014-03-13 ES ES14773506.2T patent/ES2688895T3/es active Active
- 2014-03-13 PT PT14773506T patent/PT2968466T/pt unknown
- 2014-03-13 NZ NZ711566A patent/NZ711566A/en unknown
- 2014-03-13 EP EP14773506.2A patent/EP2968466B1/en active Active
- 2014-03-13 DK DK14773506.2T patent/DK2968466T3/en active
- 2014-03-13 WO PCT/US2014/026841 patent/WO2014160495A1/en active Application Filing
- 2014-03-13 PL PL14773506T patent/PL2968466T3/pl unknown
- 2014-03-13 MY MYPI2015002308A patent/MY174679A/en unknown
- 2014-03-13 HU HUE14773506A patent/HUE039948T2/hu unknown
- 2014-03-13 KR KR1020157027940A patent/KR102237885B1/ko active IP Right Grant
- 2014-03-13 LT LTEP14773506.2T patent/LT2968466T/lt unknown
- 2014-03-13 AU AU2014243700A patent/AU2014243700B2/en active Active
-
2015
- 2015-08-31 IL IL24093315A patent/IL240933B/en active IP Right Grant
- 2015-09-02 MX MX2019013560A patent/MX2019013560A/es unknown
- 2015-09-16 ZA ZA2015/06876A patent/ZA201506876B/en unknown
- 2015-12-08 HK HK15112071.0A patent/HK1211219A1/xx unknown
-
2018
- 2018-04-24 JP JP2018083450A patent/JP2018150317A/ja not_active Withdrawn
- 2018-09-20 HR HRP20181504TT patent/HRP20181504T1/hr unknown
-
2019
- 2019-04-09 AU AU2019202464A patent/AU2019202464B2/en active Active
- 2019-09-13 ZA ZA2019/06057A patent/ZA201906057B/en unknown
-
2020
- 2020-05-27 JP JP2020091966A patent/JP2020164531A/ja active Pending
-
2021
- 2021-03-02 AU AU2021201366A patent/AU2021201366A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY191169A (en) | Anti-fcrh5 antibodies | |
HK1247854A1 (zh) | 混合變應原組合物及其使用方法 | |
CL2016002772A1 (es) | Composiciones de insulina de rápida acción | |
MX2015008999A (es) | Inhibidores mk2 y usos de los mismos. | |
WO2015038796A3 (en) | Secretion of heme-containing polypeptides | |
PH12014502132A1 (en) | Anti-lgr5 antibodies and immunoconjugates | |
MX2019013560A (es) | Formulaciones con oxidacion reducida. | |
SG10201913040SA (en) | Compositions and methods for stabilizing flaviviruses with improved formulations | |
WO2015120062A3 (en) | Therapeutic compounds and compositions | |
IN2015DN00127A (es) | ||
PL3411432T3 (pl) | Kompozycja wulkanizująca zawierająca cyklododekasiarkę i ulepszony związek cyklododekasiarki | |
PH12017502028A1 (en) | Vortioxetine pyroglutamate | |
AR095398A1 (es) | Formulaciones con oxidación reducida | |
EP3297440A4 (en) | COMPOSITION WITH CARBOPLATIN AND USE | |
IN2014DN11078A (es) | ||
SG10201900598TA (en) | Factor viii formulation | |
EP3527225A4 (en) | COMPOSITION CONTAINING ANTI-ROBO4 ANTIBODY AND OTHER AGENT | |
PH12017502148A1 (en) | Pharmaceutical compositions and use thereof | |
EP3153492A4 (en) | Novel compound and fragrance composition containing same | |
GEP20217236B (en) | Composition comprising pentose and polyphenolic compound | |
MX2015011433A (es) | Formulaciones con oxidacion reducida. | |
EP3568203C0 (en) | COMPOUNDS AND COMPOSITIONS | |
GB201614961D0 (en) | Compounds and compositions for use | |
BR112017001483A2 (pt) | “composições nutricionais contendo pó de fosfatidilserina” | |
EP3570833A4 (en) | ANESTHETIC COMPOSITIONS AND PROCEDURES USING IMIDAZOLINE COMPOUNDS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |